The Journal of Urology
Volume 179, Issue 2 , Pages 743-747 , February 2008

Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer

  • Mohammad Obaidul Hoque

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence: Department of Otolaryngology and Head and Neck Surgery, The Johns Hopkins University School of Medicine, 1550 Orleans St., CRB II, 5N.03, Baltimore, Maryland 21231 (telephone: 410-502-5153 or 410-502-8778; FAX: 410-614-1411).
    • Financial interest and/or other relationship with GlaxoSmithKline, Elsevier, Teng, Viventia and Pfizer.
  • ,
  • Shahnaz Begum

      Affiliations

    • Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
  • ,
  • Mariana Brait

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Carmen Jeronimo

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Marianna Zahurak

      Affiliations

    • Department of Biostatistics/Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Kimberly Laskie Ostrow

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Eli Rosenbaum

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Bruce Trock

      Affiliations

    • The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland
  • ,
  • William H. Westra

      Affiliations

    • Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
  • ,
  • Mark Schoenberg

      Affiliations

    • The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland
  • ,
  • Steven N. Goodman

      Affiliations

    • Department of Biostatistics/Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • David Sidransky

      Affiliations

    • Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence: Department of Otolaryngology and Head and Neck Surgery, The Johns Hopkins University School of Medicine, 1550 Orleans St., CRB II, 5N.03, Baltimore, Maryland 21231 (telephone: 410-502-5153 or 410-502-8778; FAX: 410-614-1411).
    • Financial interest and/or other relationship with Oncomethylome Sciences.

Received 23 December 2005

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received approval from The Johns Hopkins Hospital institutional review board.Supported by National Cancer Institute Grant U01-CA84986, Oncomethylome Sciences, SA, a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (MOH) and a Young Investigator Award from the International Association for the Study of Lung Cancer (MOH).

PII: S0022-5347(07)02490-1

doi: 10.1016/j.juro.2007.09.019

The Journal of Urology
Volume 179, Issue 2 , Pages 743-747 , February 2008